logo
Dr. Rania Al-Mashat Discusses Strengthening Health Policies in the Medium-Term Development Plan with World Health Organization (WHO) Regional Director for Eastern Mediterranean

Dr. Rania Al-Mashat Discusses Strengthening Health Policies in the Medium-Term Development Plan with World Health Organization (WHO) Regional Director for Eastern Mediterranean

Zawya12-07-2025
H.E. Dr. Rania A. Al-Mashat, Minister of Planning, Economic Development and International Cooperation, received Dr. Hanan Balkhy, World Health Organization (WHO) Regional Director for the Eastern Mediterranean, during her visit to Egypt. The meeting was attended by Dr. Nima Saeed, WHO Representative to Egypt, and focused on ways to strengthen joint cooperation.
At the beginning of the meeting, H.E. Dr. Rania Al-Mashat welcomed Dr. Hanan Balkhy, and lauded the constructive collaboration between the Egyptian government and WHO through national plans and presidential initiatives.
The Minister expressed aspiration for further cooperation in light of the state's prioritization of developing healthcare services and implementing the Universal Health Insurance System.
During the meeting, H.E. Dr. Al-Mashat reviewed the mandate and work files of the Ministry of Planning, Economic Development and International Cooperation, and its role in preparing the economic and social development plan and managing public investments for various sectors.
She highlighted the coordination with international development partners to enhance the role of UN organizations in Egypt, especially given the Ministry's role as the national coordinator and rapporteur for the 2030 Agenda.
H.E. Dr. Al-Mashat pointed to the ongoing efforts to strengthen multilateral and bilateral development partnerships, including the United Nations Sustainable Development Cooperation Framework 'UNSDCF' (2023–2027), and bilateral relations with development partners.
H.E. Minister Al-Mashat referred to the new Planning Law in Egypt and its integration with the unified Public Finance Law. She noted that the Ministry is also working on developing the annual economic and social development plan, and starting from the next fiscal year 2026/2027, a medium-term plan for three years with clear targets will be developed, which will promote evidence- and data-based development policies.
H.E. Dr. Al-Mashat affirmed that ongoing cooperation with WHO is central to Egypt's comprehensive national vision and reflects the state's commitment to achieving the primary goal of Egypt Vision 2030: "Improving the quality of life for all Egyptians and raising their living standards."
H.E. Minister Al-Mashat also indicated that providing equitable and high-quality healthcare is a fundamental human right and a key tool for achieving social justice and national development.
H.E. Dr. Rania Al-Mashat reviewed the progress in Egypt's GDP for the third quarter of the last fiscal year, which recorded 4.7%, exceeding expectations despite regional challenges and global tensions.
She also noted the targets of the economic and social development plan for the current fiscal year, which allocates approximately 45% of government investments to various human development sectors.
For her part, Dr. Hanan Balkhy expressed gratitude to the Minister of Planning, Economic Development and International Cooperation for the continuous coordination and ongoing cooperation to support UN organizations through international partnerships.
She affirmed WHO's appreciation for its partnership with the Egyptian government and praised Egypt's advancements in combating diseases and enhancing healthcare services, as well as strengthening pharmaceutical security through the expansion of medicine and vaccine manufacturing.
The two sides also discussed cooperation within the framework of WHO's "Health in All Policies" approach, which aims to integrate health considerations into policymaking across all government sectors.
In this regard, H.E. Dr. Al-Mashat welcomed the initiative, emphasizing that this approach aligns with the state's endeavors to foster evidence-based policymaking and develop Egypt's planning system by starting the preparation of a medium-term plan from the next fiscal year. She also underscored Egypt's Integrated National Financing Strategy (E-INFS) for Sustainability and Development, which represents a roadmap for financing development across various sectors, including health and human development sectors.
Distributed by APO Group on behalf of Ministry of Planning, Economic Development, and International Cooperation - Egypt.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MBRU scientists publish first Arab Pangenome Reference in major genomic breakthrough
MBRU scientists publish first Arab Pangenome Reference in major genomic breakthrough

Economy ME

time14 hours ago

  • Economy ME

MBRU scientists publish first Arab Pangenome Reference in major genomic breakthrough

Scientists at the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), the academic and research arm of Dubai Health , have achieved a major milestone in global genomic science with the publication of the first Arab Pangenome Reference. Featured in Nature Communications , a leading peer-reviewed journal, the study marks a pivotal advancement in precision medicine and personalized healthcare for Arab populations. The landmark achievement supports the UAE's National Genome Strategy, a 10-year initiative launched in 2023 by the Emirates Genome Council. The strategy aims to transform healthcare in the UAE through cutting-edge genomic research focused on personalized, preventive, and precision medicine. The Arab Pangenome Reference was created using high-quality DNA sequencing from 53 individuals of diverse Arab heritage residing in the UAE. Conducted at MBRU's state-of-the-art Center for Applied and Translational Genomics (CATG), the research identified more than 110 million base pairs of novel DNA sequences. Additionally, it uncovered nearly 9 million small genetic variations and over 235,000 large structural differences unique to Arab populations — none of which had been previously reported in global DNA references. Read: Sheikh Hamdan awards golden visas to nurses with 15+ years of service at Dubai Health Leadership insights Professor Alawi Alsheikh-Ali , director general, Dubai Health Authority (DHA), and co-author of the study, said: 'This achievement strengthens the UAE's position in genomic science. By building a reference that reflects the genetic diversity of Arab populations, we are enabling more precise and equitable healthcare. It's a foundational step towards realising the goals of our National Genome Strategy and ensuring that future medical innovations are shaped by data from our own communities.' Dr. Hanan Al Suwaidi, acting Provost of MBRU, and co-author of the study said: 'The capabilities of the CATG lab were central to the success of this project. From genetic sequencing to advanced bioinformatics, every stage of the research was completed in-house. This level of integration gave us full control over quality and timelines, reflecting Dubai Health's commitment to building world-class infrastructure and fostering national scientific leaders.' Dr. Mohammed Uddin, director of CATG and associate professor of Genetics at MBRU, and senior author of the study, said: 'This pangenome reference marks a major advancement in our understanding of Arab genomic diversity. It serves as a critical resource for both research discovery and clinical genome diagnostics, with lasting impact for future generations across the region.' Professor Alawi Alsheikh-Ali, director general, Dubai Health Authority (DHA) Addressing gaps in global genomic databases Historically, global genomic databases have significantly underrepresented Arab populations, limiting the accuracy of genetic risk assessment and treatment strategies for these communities. The Arab Pangenome Reference fills a critical gap by introducing high-resolution genomic data from a population long absent in international references. One particularly notable finding from the study was the discovery of the duplicated gene TAF11L5, which is highly enriched among Arab individuals but missing in existing global genomic references. Researchers believe this gene could influence the regulation of other genes and may hold important insights into disease risk and variations in treatment response. Enabling precision healthcare in the Arab World The Arab Pangenome Reference provides a foundational tool for national and regional precision medicine initiatives. It enables the development of population-specific biomarkers, disease risk models, and targeted therapies — advancing the region's ability to deliver more accurate, personalized healthcare solutions. Alongside the genomic map, the research team also introduced a new bioinformatics tool called PanScan. Designed to support more complex analysis of human pangenomes, PanScan helps researchers detect gene duplications, novel DNA variants, and complex genomic structures. Though not the main focus of the study, the tool has been made freely available on GitHub, offering global researchers access to further investigate human genomic diversity. The strategy aims to transform healthcare in the UAE through cutting-edge genomic research focused on personalized, preventive, and precision medicine A strategic step toward global representation Genomic research has progressed rapidly in recent decades, but much of the foundational data has come from a limited range of populations, creating blind spots in medical understanding. The Arab Pangenome Reference contributes to a growing international effort to correct this imbalance and promote global inclusivity in genomic science. The initiative also reflects Dubai Health's long-term commitment to research and innovation through MBRU. By investing in foundational studies such as this, Dubai Health is ensuring that Arab populations are actively represented in the future of genomics and precision healthcare. This groundbreaking research not only elevates the UAE's position in global genomic science but also lays the groundwork for more equitable, effective, and personalized healthcare systems across the Arab World.

Advanced surgical services launched at Burjeel Day Surgery Centre in Al Dhahir
Advanced surgical services launched at Burjeel Day Surgery Centre in Al Dhahir

Zawya

time17 hours ago

  • Zawya

Advanced surgical services launched at Burjeel Day Surgery Centre in Al Dhahir

Dr. Sultan Al Neyadi, Minister of State for Youth Affairs, has attended the inauguration of advanced surgical services at the Burjeel Day Surgery Centre (BDSC) in Al Dhahir, Al Ain. The celebration was attended by senior leadership from Burjeel Holdings, including Dr. Shamsheer Vayalil, Founder and Chairman; John Sunil, CEO; and Omran Al Khoori, Member of the Board of Directors. The gathering also marked the inauguration of the second phase of BDSC's Operating Theatres. This expansion reflects the centre's commitment to enhancing the quality and efficiency of healthcare services provided to citizens and residents of Al Ain, particularly the local communities in and around the Al Dhahir area. 'This milestone reflects our commitment to building healthcare systems around the needs of people and communities. The successful integration of surgical services at BDSC will enhance the offerings for the community,' said Dr. Aysha Almahri, CEO, Al Ain Region, Burjeel Holdings. 'Our enhanced capabilities mean patients can now receive the care they need, quickly, safely, and close to home. We are proud to be a trusted partner for the community and will continue expanding services in response to local needs,' said Dr. Mohamed Hassan Abbass Hassan Elshamsy, Medical Director and Consultant in Ophthalmology at BDSC, Al Dhahir.

Alibaba DAMO Academy collaborates with United Nations and hospitals to advance AI for good initiatives
Alibaba DAMO Academy collaborates with United Nations and hospitals to advance AI for good initiatives

Zawya

time19 hours ago

  • Zawya

Alibaba DAMO Academy collaborates with United Nations and hospitals to advance AI for good initiatives

Dubai, United Arab Emirates - Alibaba DAMO Academy, the global research arm of Alibaba Group, has entered into a strategic collaboration with the International Telecommunication Union (ITU), a specialized agency of the United Nations focused on information and communication technologies (ICTs). The partnership aims to promote the use of artificial intelligence (AI) in addressing pressing global challenges, particularly in the fields of healthcare, climate change, and scientific discovery. Announced at the AI for Good Global Summit 2025, this collaboration will facilitate expert exchanges and knowledge-sharing mechanisms between the two organizations. It will also support initiatives of AI for Health, AI for Climate, and AI for Science through a series of joint activities, including online lectures and offline events. Additionally, both parties plan to explore cooperation in robotics and embodied intelligence, while deepening their work in AI and video technologies, contributing to global technological development, solution deployment, and standardization. As part of its broader commitment to advancing AI capacity building, Alibaba DAMO Academy has also joined the AI Skills Coalition, a global, open, trusted, and inclusive platform led by the United Nations. As a founding member, Alibaba DAMO Academy will support the Coalition's mission to empower governments, businesses, and organizations—particularly those in less developed countries—to harness AI for sustainable development and good governance. Advancing AI for Health in Singapore and Saudi Arabia To advance AI for Health initiatives globally, Alibaba DAMO Academy has also announced a collaboration with NHG Health in Singapore to drive innovation in AI-powered medical research and clinical applications at Tan Tock Seng Hospital (TTSH), one of the country's largest multi-disciplinary hospitals. This partnership leverages the combined expertise of both organizations in medical AI technology and scientific research. The focus is on enhancing early screening for conditions such as pancreatic cancer, osteoporosis, sarcopenia, breast cancer, and kidney masses. Through joint research, development, and external validation, the collaboration aims to expand access to AI-driven early detection tools, ultimately supporting the advancement of precision medicine and enabling more timely and effective treatments. Additionally, Alibaba DAMO Academy will collaborate with Abdul Latif Jameel Health, the health division of the Saudi Arabia-based multinational enterprise Abdul Latif Jameel Group, to explore opportunities in AI-assisted diagnosis for cancers such as pancreatic, gastric, and esophageal cancer, chronic diseases like cardiovascular disease, osteoporosis, and fatty liver disease, as well as acute conditions including acute aortic syndromes and pulmonary embolism. This collaboration seeks to extend the benefits of medical AI to more people and regions by combining Alibaba DAMO Academy's cutting-edge technology products with Abdul Latif Jameel Health's extensive global network. Recognition of DAMO Academy's Innovation in AI for Good Alibaba DAMO Academy's technological innovations have been acknowledged in the United Nation's AI for Good Innovate for Impact Interim Report 2025. Among its frontier AI solutions is Baguan AI Weather Forecasting , which generates specialized weather indicators for applications in power energy, agricultural meteorology, low-altitude weather forecasting, and regional renewable energy planning. Another notable achievement is the DAMO PANDA system (Pancreatic Cancer Detection with Artificial Intelligence), which uses deep learning to detect and classify pancreatic lesions with high accuracy using non-contrast CT scans. Recently, it developed DAMO GRAPE (Gastric Cancer Risk Assessment Procedure with Artificial Intelligence), a deep-learning framework that analyzes 3D non-contrast CT scans to detect and segment gastric cancer with high sensitivity and specificity. These innovations exemplify Alibaba DAMO Academy's commitment to leveraging AI for societal benefit and advancing the frontiers of science and healthcare globally. -Ends- About Alibaba Cloud Established in 2009, Alibaba Cloud ( is the digital technology and intelligence backbone of Alibaba Group. It offers a complete suite of cloud services to customers worldwide, including elastic computing, database, storage, network virtualization services, large-scale computing, security, big data analytics, machine learning and artificial intelligence (AI) services. Alibaba has been named the leading IaaS provider in Asia Pacific by revenue in U.S. dollars since 2018, according to Gartner. It has also maintained its position as one of the world's leading public cloud IaaS service providers since 2018, according to IDC. Media Contact Ribal Temraz APCO Worldwide rtemraz@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store